Analystreport

Fulcrum Therapeutics (NASDAQ:FULC) had its "positive" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report